Authors: Sajida Perveen, Majida Khanam, Peter Bailie, Shehnaz Hassan
Abstract
To compare the effectiveness of Bromocriptine Mesylate (1.25mg) Vs human albumin (50ml) in patients who were at high risk of Ovarian Hyper-stimulation Syndrome (OHSS) STUDY DESIGN: comparative study. PLACE AND DURATION OF STUDY: Baqai institute of Reproduction and developmental Sciences (BIRDS) from January 2008 till December 2009. METHODOLOGY: 60 women who were at high risk of OHSS were selected for prophylaxis of OHSS. 30 women (group 1) were given oral bromocriptine mesylate in a dose of 1.25 mg started from day of ovum pick up at bed time for 7 days and rest 30 women (group 2) received 50 ml human albumin infusion at time of oocyte retrieval and embryo transfer for prophylaxis of OHSS as a standard treatment.
Follow up of all these women were done. Any woman who presented with sign/symptoms,
suspected of OHSS was hospitalized for further observation and management. RESULTS: Age range of women was 20 – 35 years and a mean age of 27.5 years. High risk factors for OHSS in both groups were detected. In group 1, PCO was found in 20 (66.6%) women. 1 (3.33%) woman was of young age (<22years). Low BMI (<18) was seen in 1(3.33%) woman .History of OHSS in previous ICSI cycle was found in 1 (3.33%) .Increased sensitivity to gonadotropins as an individuals response was seen in 4 (13.33%) .Day 3 FSH < 7 IU/L was found in 3(10%) women .While in group 2 , 21(70%) women had PCO , 1(3.33%) woman was of young age ,1 (3.33%) woman had BMI < 18 .Increased sensitivity to gonadotropins was found in 4 (13.33%) women. Day 3 FSH < 7 IU /L was found in 3(10%) women. In group 1 ,mild OHSS was found in 13.33% women and moderate in 3.33% women .No woman had severe OHSS. While in group 2 , mild OHSS was seen in 43.33% women ,moderate in 20% and severe in 3.33% women. CONCLUSION: Bromocriptine in low doses was found effective for prevention of OHSS as compare to human albumin infusion in studied sample.
Keywords: Bromocriptine, Ovarian Hyperstimulation Syndrome, Gonadotropins.
